Human Olfactory Neurosphere-derived Cells: A Novel Cellular Model For Parkinson's Disease.
Funder
National Health and Medical Research Council
Funding Amount
$365,126.00
Summary
ParkinsonÍs disease (PD) is an incurable, brain disease that affects 75,000 Australians with great societal cost. We are working on adult stem cells called (hONS) grown from peopleÍs olfactory mucosa (in the nose) as a research tool to study PD. Our project examines differences seen in hONS from people with PD and determines how certain cellular processes impact on the function of these cells. This work will enhance our understanding of the biology of PD and identify new targets for therapies.
Containment Potential And Risk Of Spread Of Artemisinin Resistant Plasmodium Falciparum
Funder
National Health and Medical Research Council
Funding Amount
$381,762.00
Summary
Significant gains have been made in the past decade in reducing falciparum malaria morbidity and mortality using artemisinin-base combination therapy (ACT) and insecticidal nets. However the recent emergence of artemisinin resistance threatens these achievements. This project will develop and use a mathematical model of malaria transmission incorporating resistance to the drugs in ACTs to investigate the probability and rate of spread of resistance into new areas endemic for malaria.
Using An Established Simulation Model To Determine Effective And Cost-effective Interventions To Mitigate Influenza Pandemics And Inform Public Health Policy
Funder
National Health and Medical Research Council
Funding Amount
$416,353.00
Summary
A novel disease spread and economic model is used to determine the cost-effectiveness of a range of mitigation strategies aimed at a future influenza pandemic. A simulation model generates data on which individuals become ill, morbidity and mortality characteristics, an economic costing model determines optimal interventions.
New High Thoughput Animal Models To Investigate Amyloid Beta Toxicity
Funder
National Health and Medical Research Council
Funding Amount
$402,223.00
Summary
Amyloid-beta is widely considered to cause Alzheimer’s disease. The majority of amyloid-beta in Alzheimer's disease brains is found as shortened forms. The role of these shortened forms is uncertain and are not being tested in current animal models. We propose to develop new models to determine and compare their respective toxic effects, and to use these new models to help identify drugs to treat Alzheimer's disease.
Discovery Of Novel Heart Failure Therapeutics Via Development Of A Next Generation Therapeutic Screening Platform: Force-generating Human Heart Tissue Micro-arrays
Funder
National Health and Medical Research Council
Funding Amount
$463,524.00
Summary
In this project we will develop a micro scale platform containing 384 miniature human heart muscle strips. The technology we develop will enable us to determine the strength of the contraction of each strip which is a model of heart function. This provides us a platform to better understand heart disease and also to screen for new drugs for heart failure.
Modelling Leber’s Hereditary Optic Neuropathy Using Human Induced Pluripotent Stem Cells
Funder
National Health and Medical Research Council
Funding Amount
$628,416.00
Summary
Leber’s Hereditary Optic Neuropathy (LHON) is a blinding disease that affects young males and is caused by the death of cells in the optic nerve. To better understand LHON, this project utilises induced pluripotent stem (iPS) cells for disease modelling. iPS cells will be generated from patients and turned into optic nerve cells, allowing us to study the diseased cells in the laboratory, providing a platform to screen for novel drugs to improve treatment options and fast-track drug development.
Does Environmental Change Drive The Spatiotemporal Transmission Dynamics Of Echinococcus Spp. In Ningxia, China?
Funder
National Health and Medical Research Council
Funding Amount
$654,548.00
Summary
Human echinococcosis is a chronic debilitating disease with a death rate that can exceed 90%. In China it is a major public health issue where recent environmental changes are likely to increase transmission rates, thus increasing the disease burden. This project will assess the impact of these environmental changes on the transmission of this disease over space and time, it will predict where new cases will arise, and determine the best methods for sustainable control and then elimination.
In this proposal, we will use genome sequencing to identify novel mutations in patients presenting with kidney disease. We will also generate stem cell lines from these patients and their unaffected relatives in order to model the disease. Finally, we will create animal models of the same mutations. As a result, we hope to better understand the causes of the disease and begin to develop new treatment options.
Cell Trafficking In A Stem Cell Model For Hereditary Spastic Paraplegia
Funder
National Health and Medical Research Council
Funding Amount
$524,082.00
Summary
Hereditary Spastic Paraplegia (HSP) is a genetic disease passed down in affected families. It is a slowly progressing lower limb paralysis that gradually restricts daily activities until the sufferer is confined to bed. There are no cures. This project investigates patientsÍ stem cells to study how HSP genes cause disease. We will use these stem cells to discover new potential drug therapies.
Physiologically-based Pharmacokinetics And Pharmacodynamics Of Therapeutic Stem Cells For Liver Disease
Funder
National Health and Medical Research Council
Funding Amount
$848,710.00
Summary
This project focuses on the challenging area of effective and optimal dosing cell-based therapy for liver diseases. We will investigate the fate and therapeutic effects of natural, modified and artificial therapeutic cells in the body and in liver regions using a physiologically-based kinetic model. Our key goal is advance cell therapy by providing a better understanding and dosing guidelines.